Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-re...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
National Academy of Sciences
2010
|
| Subjects: |
| _version_ | 1796945228211421184 |
|---|---|
| author | Patel, Nish Chatterjee, Sabarni K. Vrbanac, Vladimir Chung, Ivy Mu, Chunyao Jenny Olsen, Rachelle R. Waghorne, Carol Zetter, Bruce R. |
| author_facet | Patel, Nish Chatterjee, Sabarni K. Vrbanac, Vladimir Chung, Ivy Mu, Chunyao Jenny Olsen, Rachelle R. Waghorne, Carol Zetter, Bruce R. |
| author_sort | Patel, Nish |
| collection | UM |
| description | Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-resistant cancers. Using a proteomics approach, elevated levels of Prohibitin1 (PHB1) and GST pi were found associated with paclitaxel resistance in discrete subcellular fractions of two drug-resistant sublines relative to their sensitive sublines. Immunofluorescence staining and fractionation studies revealed increased levels of PHB1 on the surface of resistant cell lines. Transiently silencing either PHB1 or GSTp gene expression using siRNA in the paclitaxel-resistant cancer cell sublines partially sensitized these cells toward paclitaxel. Intriguingly, silencing PHB1 but not GSTp resulted in activation of the intrinsic apoptosis pathway in response to paclitaxel. Similarly, stably silencing either PHB1 or GSTp significantly improved paclitaxel sensitivity in A549TR cells both in vitro and in vivo. Our results indicate that PHB1 is a mediator of paclitaxel resistance and that this resistance may depend on the cellular localization of the protein. We suggest PHB1 as a potential target for therapeutic strategies for the treatment of drug-resistant tumors. |
| first_indexed | 2024-03-06T05:13:31Z |
| format | Article |
| id | um.eprints-5085 |
| institution | Universiti Malaya |
| last_indexed | 2024-03-06T05:13:31Z |
| publishDate | 2010 |
| publisher | National Academy of Sciences |
| record_format | dspace |
| spelling | um.eprints-50852018-10-24T04:19:34Z http://eprints.um.edu.my/5085/ Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells Patel, Nish Chatterjee, Sabarni K. Vrbanac, Vladimir Chung, Ivy Mu, Chunyao Jenny Olsen, Rachelle R. Waghorne, Carol Zetter, Bruce R. R Medicine Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-resistant cancers. Using a proteomics approach, elevated levels of Prohibitin1 (PHB1) and GST pi were found associated with paclitaxel resistance in discrete subcellular fractions of two drug-resistant sublines relative to their sensitive sublines. Immunofluorescence staining and fractionation studies revealed increased levels of PHB1 on the surface of resistant cell lines. Transiently silencing either PHB1 or GSTp gene expression using siRNA in the paclitaxel-resistant cancer cell sublines partially sensitized these cells toward paclitaxel. Intriguingly, silencing PHB1 but not GSTp resulted in activation of the intrinsic apoptosis pathway in response to paclitaxel. Similarly, stably silencing either PHB1 or GSTp significantly improved paclitaxel sensitivity in A549TR cells both in vitro and in vivo. Our results indicate that PHB1 is a mediator of paclitaxel resistance and that this resistance may depend on the cellular localization of the protein. We suggest PHB1 as a potential target for therapeutic strategies for the treatment of drug-resistant tumors. National Academy of Sciences 2010 Article PeerReviewed Patel, Nish and Chatterjee, Sabarni K. and Vrbanac, Vladimir and Chung, Ivy and Mu, Chunyao Jenny and Olsen, Rachelle R. and Waghorne, Carol and Zetter, Bruce R. (2010) Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 107 (6). pp. 2503-2508. ISSN 1091-6490, DOI https://doi.org/10.1073/pnas.0910649107 <https://doi.org/10.1073/pnas.0910649107>. https://doi.org/10.1073/pnas.0910649107 doi:10.1073/pnas.0910649107 |
| spellingShingle | R Medicine Patel, Nish Chatterjee, Sabarni K. Vrbanac, Vladimir Chung, Ivy Mu, Chunyao Jenny Olsen, Rachelle R. Waghorne, Carol Zetter, Bruce R. Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells |
| title | Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells |
| title_full | Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells |
| title_fullStr | Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells |
| title_full_unstemmed | Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells |
| title_short | Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells |
| title_sort | rescue of paclitaxel sensitivity by repression of prohibitin1 in drug resistant cancer cells |
| topic | R Medicine |
| work_keys_str_mv | AT patelnish rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT chatterjeesabarnik rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT vrbanacvladimir rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT chungivy rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT muchunyaojenny rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT olsenracheller rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT waghornecarol rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells AT zetterbrucer rescueofpaclitaxelsensitivitybyrepressionofprohibitin1indrugresistantcancercells |